If the forces driving this were about epidemiology, then we'd have
— Mark Changizi (@MarkChangizi) December 13, 2021
- done cost-benefit analyses
- not done lockdowns (ruled out pre 2020)
- not mandated masks (all RCTs show don't work)
- not sacrificed free expression, informed consent, and civil rights. https://t.co/ir01ct6Jwv
Nor our puberty-aged children whose reproductive life they want to destroy.
See ya, Cali… https://t.co/hcZ5q206i8 pic.twitter.com/1W1OsGLEO9
— Dave Rubin (@RubinReport) December 13, 2021
Hospitals Dropping Vax Mandate Due To Labor Shortages, Court Order
— zerohedge (@zerohedge) December 13, 2021
Attorney Ralph Lorigo has won almost all of his MANY cases suing to get IVM to dying patients. Every time the hospital refuses, delays or appeals. Now its THEIR turn to pay… instead of the patient. One hospital will owe 50K if IVM not given by 9pm. Gee, I wonder what they’ll do? https://t.co/IgAZlu8bsP
— Pierre Kory, MD MPA (@PierreKory) December 13, 2021
@deNutrients https://t.co/9PFakc2cUX
— Robert E Most, MD (@LNeuroscientist) December 13, 2021
Try Artemisinin to detox Covid vaccine side effects. https://t.co/DgGCgVivtH
— zhang (@zhang32071674) December 13, 2021
Artemisinin is an antiparasitic that is derived from the sweet wormwood plant, considered by some to be THE antidote to COVID-19.
Artemisinin targets 124 different parasite proteins.
The researchers were unsurprised to find that the probe bound to a whopping 124 different proteins. “The highly reactive and fast-acting nature of activated artemisinin suggests that it most likely has multiple targets,” Lin says. The fact that the drug has developed only low-level resistance after decades of extensive use bolsters this idea, too.
Artemisinin needs heme, an iron-containing component of the red blood protein hemoglobin, to be activated.
“The central finding is consistent with previous lines of thought: Artemisinin has a fuse that is lit in the heme-rich parasite, where it then indiscriminately attacks like a bomb,” says Leila S. Ross, a postdoc studying malaria drug resistance in David A. Fidock’s lab at Columbia University. “Artemisinin kills by jamming up a large variety of cellular processes rather than a single pathway.”
It looks like Artemisinin is stronger than Hydrochloroquine. So whatever Hydrochloroquine can't take out, Artemisinin will,
Artemisinin is effective against all the malaria-causing protozoal organisms in the genus Plasmodium. The drug is particularly useful in the treatment of infections involving chloroquine-resistant parasites and infections involving multidrug-resistant P. falciparum, which is the deadliest of the malaria protozoans.
Good to know.
Artemisinin also fights different kinds of cancers.
Artemisinin is effective against a wide variety of cancers as shown in a series of successful experiments. The most effective is leukemia and colon cancer. Intermediate activities were also shown against melanoma, breast, ovarian, prostate, CNS and renal cancer. Although artemisinin is insoluble in water, it is able to cross the blood brain barrier (the water soluble artesunate is the weakness among the derivates) and may be particularly suitable for curing brain tumors, together with Poly-MVA (an metalo-vitamin)
On dosage, Briticanna states that
Artemisinin appears to have few side effects in humans. However, animal studies have shown that high doses can elicit symptoms of neurotoxicity, including respiratory depression and unsteady gait. These symptoms are associated with degeneration of the brainstem, though it remains unclear whether similar neurodegenerative effects occur at high doses in humans.
Looks like Dr. Mercola also knew of Artemisinin back at the beginning of the year.
